Aventis Pegs Injectable Flu Vaccine As Key Sales Growth Driver
Executive Summary
Aventis Pasteur sees increased utilization of its injectable influenza vaccine as a key sales driver for the company going forward
You may also be interested in...
Sanofi-Aventis Menactra Approved; Launch Awaits ACIP Recommendations
Sanofi-Aventis' launch of its meningococcal conjugate vaccine Menactra will await formal recommendations for use by the Centers for Disease Control & Prevention's Advisory Committee on Immunization Practices next month
Sanofi-Aventis Menactra Approved; Launch Awaits ACIP Recommendations
Sanofi-Aventis' launch of its meningococcal conjugate vaccine Menactra will await formal recommendations for use by the Centers for Disease Control & Prevention's Advisory Committee on Immunization Practices next month
Aventis Menactra May Get CDC Endorsement For Teens And College Freshmen
A working group of the Centers for Disease Control & Prevention's Advisory Committee on Immunization Practices favors a future recommendation of routine vaccination with meningococcal vaccine for adolescents and college freshmen in dorms